MacroGenics
MGNX
128 hedge funds and large institutions have $831M invested in MacroGenics in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 26 reducing their positions, and 11 closing their positions.
275% more call options, than puts
Call options by funds: $285K | Put options by funds: $76K
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
123% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 26
33% more capital invested
Capital invested by funds: $627M → $831M (+$205M)
13% more funds holding
Funds holding: 113 → 128 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$16.5M |
| 2 |
O
OrbiMed
New York
|
+$10.4M |
| 3 |
O
OppenheimerFunds
New York
|
+$8.42M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.72M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DFO
Duquesne Family Office
New York
|
-$14.8M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$8.22M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$4.02M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.86M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.99M |
MGNX Hedge Fund Activity: Q2 2015 in Review
128 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2015, worth a combined $831M — up 33% from $627M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MGNX positions and 11 closed out — a net gain of 15 holders — while 58 added to existing stakes and 26 trimmed.
The largest buyer was Pinnacle Associates, opening a new position worth an estimated $16.5M. The largest seller was Duquesne Family Office, exiting entirely with an estimated $14.8M sold.
- 128 institutional investors held MacroGenics (MGNX) as of Q2 2015, up from 113 in Q1 2015.
- Funds reported $831M of MacroGenics stock for Q2 2015, up 33% quarter-over-quarter.
- 26 funds opened new MacroGenics positions in Q2 2015 and 11 closed out, a net change of +15 holders.
- The largest MacroGenics buyer in Q2 2015 was Pinnacle Associates, an estimated $16.5M added.
- The largest MacroGenics seller in Q2 2015 was Duquesne Family Office, an estimated $14.8M sold.
Based on aggregated 13F filings for Q2 2015.